Corrigendum to “Geniposide via enema alleviates colitis by modulating intestinal flora and bile acid metabolites, inhibiting S100A8/S100A9/NF-κB, and promoting TGR5 inhibition of NLRP3 inflammasome” [Phytomedicine, 142 (2025), 156791]

IF 6.7 1区医学 Q1 CHEMISTRY, MEDICINAL

Phytomedicine Pub Date : 2025-06-13 DOI:10.1016/j.phymed.2025.156934

Bao-xin Zheng , Yan Yi , Xing-wen Wang , Chun-ying Li , Yong Zhao , Jing-zhuo Tian , Lian-mei Wang , Jia-yin Han , Chen Pan , Su-yan Liu , Chen-yue Liu , Sha-Sha Qin , Xuan Tang , Mei-ting Liu , Ai-hua Liang

引用次数: 0

查看原文本刊更多论文

“京尼平苷灌肠通过调节肠道菌群和胆汁酸代谢物，抑制S100A8/S100A9/NF-κB，促进TGR5对NLRP3炎症小体的抑制来缓解结肠炎”[植物医学，142(2025),156791]。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Phytomedicine 医学-药学

CiteScore

10.30

自引率

5.10%

发文量

670

审稿时长

91 days

期刊介绍： Phytomedicine is a therapy-oriented journal that publishes innovative studies on the efficacy, safety, quality, and mechanisms of action of specified plant extracts, phytopharmaceuticals, and their isolated constituents. This includes clinical, pharmacological, pharmacokinetic, and toxicological studies of herbal medicinal products, preparations, and purified compounds with defined and consistent quality, ensuring reproducible pharmacological activity. Founded in 1994, Phytomedicine aims to focus and stimulate research in this field and establish internationally accepted scientific standards for pharmacological studies, proof of clinical efficacy, and safety of phytomedicines.